The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.
Contains Bayesian implementations of the Mixed-Effects Accelerated Failure Time (MEAFT) models for censored data. Those can be not only right-censored but also interval-censored, doubly-interval-censored or misclassified interval-censored. The methods implemented in the package have been published in Komárek and Lesaffre (2006, Stat. Modelling) <doi:10.1191/1471082X06st107oa>, Komárek, Lesaffre and Legrand (2007, Stat. in Medicine) <doi:10.1002/sim.3083>, Komárek and Lesaffre (2007, Stat. Sinica) <https://www3.stat.sinica.edu.tw/statistica/oldpdf/A17n27.pdf>, Komárek and Lesaffre (2008, JASA) <doi:10.1198/016214507000000563>, García-Zattera, Jara and Komárek (2016, Biometrics) <doi:10.1111/biom.12424>.
Version: | 3.8 |
Depends: | R (≥ 3.0.0), survival, coda, smoothSurv |
Imports: | graphics, stats, utils |
Published: | 2024-09-16 |
DOI: | 10.32614/CRAN.package.bayesSurv |
Author: | Arnošt Komárek [aut, cre] |
Maintainer: | Arnošt Komárek <arnost.komarek at mff.cuni.cz> |
License: | GPL-2 | GPL-3 [expanded from: GPL (≥ 2)] |
URL: | https://msekce.karlin.mff.cuni.cz/~komarek/ |
NeedsCompilation: | yes |
Citation: | bayesSurv citation info |
CRAN checks: | bayesSurv results |
Reference manual: | bayesSurv.pdf |
Package source: | bayesSurv_3.8.tar.gz |
Windows binaries: | r-devel: bayesSurv_3.8.zip, r-release: bayesSurv_3.8.zip, r-oldrel: bayesSurv_3.8.zip |
macOS binaries: | r-release (arm64): bayesSurv_3.8.tgz, r-oldrel (arm64): bayesSurv_3.8.tgz, r-release (x86_64): bayesSurv_3.8.tgz, r-oldrel (x86_64): bayesSurv_3.8.tgz |
Old sources: | bayesSurv archive |
Reverse suggests: | icensBKL |
Please use the canonical form https://CRAN.R-project.org/package=bayesSurv to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.